The diverse and interesting biological activity of thiadiazoleshas been reported 1-4It is well known that these heterocyclesare valuable building blocks. Many methods for preparationof these heterocyclic ring systems and their fusedanalogues have been described in the literature 5-6. 1,3,4-thiadiazoles provided a usefulmethod for the synthesis of thiadiazolopyrimidine 7.Pyrimidine derivatives have been found to be associated with diverse biological activities and numerous reportshave appeared in the literature 8-12. This highlighted their chemistry and use. The pyrimidine derivatives haveremarkable pharmacological activity 13,14 and widely used in the field of anti-microbial, antiviral, etc. Thiadiazole derivatives were shown to possess many biological activities including anti-inflammatory 15-16.TheThe introduction of a substituent at position 6 of the1,3,4-thiadiazolo [3,2-a] pyrimidine system efficientlyenhances the physiological activity of the molecule17-19. This replacement occurs in the reactions of 1,3,4 -thiadiazolo [3,2-a] pyrimidine derivatives withelectrophiles20,21.Derivatives of 1,3,4-thiadiazolo [3,2-alpyrimidine are potential biologically active substances,22-25 The introductionof ketene dithioacetal fragments into the moleculesmakes it possible to synthesize heterocyclic systemswith various functional groups26,27.We Preparated2-R5-oxo 5-H 6 -Carbomorpholin 7-phenyl 1,3,4-thiadiazolo-[3,2-a] pyrimidine in two stage. In step first we have synthesize2-R5-oxo5-H6-EthylCarboxilate7-phenyl 1,3,4-thiadiazolo[3,2,-a]pyrimidine(3) with use2- R 5-amino 1,3,4- thiadiazole(1) andethyl 2- formyl 3- oxo 3- phenyl propanoate (2 )(Figure 1).
Table 1.synthesisof2- R 5-oxo5-H6-Carbomorpholin 7-phenyl -1,3,4-thiadiazolo [3,2-a] pyrimidinefrom 2- R5-oxo5-H6-ethylcarboxylate7-phenyl1 ,3,4- thiadiazolo [3,2-a] pyrimidineand morpholina
In another stage 2-R5-Oxo5-H6-EthylCarboxilate7-phenyl 1,3,4-thiadiazolo-[3,2,-a]pyrimidinereacted with morpholin(4) until produced 2-R 5-oxo 5-H 6 –Carbomorpholin 7 -phenyl 1,3,4-thiadiazolo-[3,2-a] pyrimidine(5-9)(f2).
http://www.orientjchem.org/wp-content/uploads/2014/04/Vol30_No1_React_Reza_fig1.jpg
Result and Discussion
we tried synthesisof 2- R 5-oxo 5-H 6-Carbomorpholin 7-phenyl -1,3,4-thiadiazolo [3,2-a] pyrimidinewith 2-R 5-oxo 5-H 6-ethylcarboxylate 7-phenyl 1 ,3,4-thiadiazolo [3,2-a] pyrimidine and morpholin in varioussolvent. But alcohols are the best solvents to this reaction .The alcoholssuch asmethanolandethanolalcoholhave more use. The herbicidal activities of the target compounds were evaluatedagainst a variety of weeds by flat-utensil method accordingwith the standard bioactivity test.Applicability of this procedures, that we synthesis a wide variety of 2-R 5-oxo 5-H 6-R-amide derivatives7-phenyl 1 ,3,4- thiadiazolo [3,2-a] pyrimidine from 2-R 5-oxo 5-H 6- ethyl carboxylate7-phenyl 1,3,4-thiadiazolo [3,2- a]pyrimidine and morpholinin the presence of alcohol ethanol at 78 oC and obtained the desirable products in good to excellent yields (Table 1).
Table 1.synthesisof2- R 5-oxo5-H6-Carbomorpholin 7-phenyl -1,3,4-thiadiazolo [3,2-a] pyrimidinefrom 2- R5-oxo5-H6-ethylcarboxylate7-phenyl1 ,3,4- thiadiazolo [3,2-a] pyrimidineand morpholina
Experimental
A mixture of 2-CH3 5-oxo 5-H 6-ethylcarboxylate 7-phenyl 1,3,4- thiadiazolo [3,2-a] pyrimidine (1 mmol),amin derivatives(1 mmol) was stirred magnetically at 78oC and the progress of the reaction was monitored by thin-layer chromatography (TLC). The reaction mixture was filtered.In all the cases, the product obtained after the usual work up gave satisfactory spectral data.For example,2-CH3 5-oxo 5-H 6-ethylcarboxylate 7-phenyl 1,3,4- thiadiazolo [3,2-a] pyrimidine (1 mmol-0.315gr),morpholin(1 mmol- 0.087gr)reacted to gether in alcoholethanol at 78 oC.Andtheproduct( 2-CH3 5-oxo 5-H 6-carbomorpholin 7-phenyl 1,3,4- thiadiazolo [3,2-a] pyrimidine )isobtainedin 85%yield.2-CH3 5-oxo 5-H 6-carbomorpholin 7-phenyl -1,3,4-thiadiazolo [3,2-a] pyrimidine:1H NMR (400 MHz, CDCl3, δ ppm): 0.9(s,3H,CH3 ););3.65(t,2H,CH2);7.30-7.46 (5H, Ph); – 13C NMR (100 MHz, CDCl3, δ ppm): 24.2(CH3),45.5 (CH2),45.5 (CH2),66.2 (CH2), 66.2 (CH2), 118 (C), 126,4 (CH) , 126,4 (CH) ,128(CH), 128.7(CH), 128.7(CH), 136.9(C), 154.7(C), 159 .8(C),162.1(C), 163 (C),168(C).
Conclusions
Compound 2- R 5-oxo 5-H 6-Carbomorpholin 7-phenyl -1,3,4-thiadiazolo [3,2-a] pyrimidine were procedure in excellent yields from 2- R 5-oxo 5-H 6-ethylcarboxylate 7-phenyl 1,3,4- thiadiazolo [3,2-a] pyrimidine and morpholinthat have a broadspectrum of antimicrobial activity .The pyrimidine derivatives haveremarkable pharmacological activity and widelyused in the field of anti-microbial, antiviral. Such medicinal utilities of the Pyrimidine derivatives prompted to synthesize the new pyrimidinethiosemicarbazide,1,3,4-thiadiazole compounds.
1. Carraro F, Pucci A, Naldini A, Schenone S, Bruno O, Ranise A,et al. Pyrazolo[3,4-d]pyrimidines endowed with antiproliferativeactivity on ductal infiltrating carcinoma cells. J Med Chem2004;47:1595–8.
2. Mylari BL, Oates PJ, Zembrowski WJ, Beebe DA, Conn EL,Coutcher JB, et al. A sorbitol dehydrogenase inhibitor ofexceptional in vivo potency with a long duration of action: 1-(R)-{4-[4-(4,6-dimethyl[1,3,5]triazin-2-yl)-2R,6Sdimethylpiperazin-1-yl]pyrimidin-2-yl}ethanol. J Med Chem 2002;45:4398–401.
3. Prekupec S, Makuc D, Plavec J, Suman L, Kralj M, Pavelic K,et al. Novel C-6 fluorinated acyclic side chain pyrimidinederivatives: synthesis, 1H and 13C NMR conformationalstudies, and antiviral and cytostatic evaluations. J Med Chem 2007;50:3037–45.
4. Gazivoda T, Sokcevic M, Kralj M, Suman L, Pavelic K, DeClercq E, et al. Synthesis and antiviral and cytostatic evaluationsof the new C-5 substituted pyrimidine and furo[2,3-d]pyrimidine40,50-didehydro-l-ascorbic acid derivatives. J Med Chem2007;50:4105–12.
5. Singh H, Yadav LDS, Shukla KN, Diwedi R. Ringtransformation of michael adducts of benzylidene-5-oxazolones and 2-amino-1,3,4-thiadiazoles to antifungal 6,7-dihydro-5(H)-thiadiazolo[3,2-a]pyrimidin-5-ones. J Agric Food Chem 1990;38:1962–4.
6. Kornis G, Marks PJ, Chidester CG. Reaction of beta-oxoesterswith 2-amino-1,3,4-thiadiazoles. A reinvestigation. J Org Chem1980;45:4860–3.
7. Cressier D, Prouillac C, Hernandez P, Amourette C, Diserbo M,Lion C, et al. Synthesis, antioxidant properties andradioprotective effects of new benzothiazoles and thiadiazoles.Bioorg Med Chem 2009;17:5275–84.
8. Kape, C,Oliver 100 years of the BiginelliDihydropyrimidine synthesis, Tetrahedron, 1993, 49, 6937 – 6963.
9. Ugi, 1.;Domling, A.; Horl, w. multi component Reactions in organic hemistry. Endeavour, 1998, 18, 115-122.
10. Kape, C O, Eur J MedChem, 2000, 35, 1043-1055.
11. C Mannich, & D Lammering, ChemBer, 1922, 5, 3510-3516.
12. A Manjula, BV Rao& P Neelakantam, Synth Commun, 2004, 34, 2665-2672.
13. J Andrew, Zych, Hong-Jun Wang, A Samuel, Sakwa, Tetrahedron Letters, 2010, 51, 5103-5105.
14. Garima, P Vishnu, Srivastava, S LalDhar, Yadav, Tetrahedron Letters, 2010, 51, 6436-6438.
15. V Sergey, Ryabukhin, S Andrey, Plaskon, S Semen, Bondarenko, N Eugeniy, Ostapchuk,O Oleksandr, Grygorenko, V Oleg, Shishkin, A Andrey, Tolmachev, Tetrahedron letters, 2010, 51, 4229-5232.
16. Hai-Ming Guo, WU Yan-Yan, Hong-Ying Nill, Dong-Chao Wang, and QuGui-Rong, J Org Chem, 2010, 75,3863-3866.
17. M.Suiko and K.Maekawa, Agric.Biol.Chem., 1977,41, 2047.
18. M.Suiko, E.Taniguchi, K.Maekawa, and M.Eto, Agric.BioL Chem., 1979, 43,741.
19. M.Suiko, E.Taniguchi, K.Maekawa, and M.Eto, BioLChem., 1979, 43, 747.
20. S.Sh.Shukurov, M.A.Kukaniev, I.M.Nasyrov, L.S.Zakharov, and R.A.Kamkhanov, Zh.Obshch.ghim., 1993,63, 2320 [Russ.J.Gen.Chem., 1993, 63 (Engl. Transl.)].
21. S.Sh.Shukurov, M.A.Kukaniev, 1.M.Nasyrov, L.S.Zakharov, and R.A.Karakhanov, lay.Akad.Nauk, Set.Khim., 1994, 908 [Russ.Chem.BAIL, t994, 43, 854 (Engl.Transl.) L.
22. Pat.2712932, Germany, RZhKhim., 1980, 9.0.171P (Russ.Transl.).
23. Pat.4742063 USA, RZhKhim., 1989, 1.0.401P (in Russian).
24. Pat.4866064 USAI RZhKhim., 1991, 7.0384P (in Russian).
25. M.Suiko and K.Maekawa, Agric.Biol.Chem., 1977,41, 2042.
26. Y.Tominaga, J.Heterocycl.Chem., 1989, 26, 1167.
27. H.Junjappa, H.Ila, and C.V.Asokan, Tetrahedron, 1990,46, 5423.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2014. This work is published under http://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
this article presents Synthesis of 2-R5-oxo 5-H 6 -Carbomorpholin 7-phenyl 1,3,4-thiadiazolo-[3,2-a] pyrimidine through reaction of 2- R 5 - Oxo 5 - H 6- EthylCarboxilate 7 – phenyl -1, 3,4 – Thiadiazolo-[3,2-a] pyrimidine with morpholin. in particular,for the new antibacterial drugs in these homologousseries of compounds, we have synthesized 2-R5-oxo 5-H 6 -Carbomorpholin 7-phenyl 1,3,4-thiadiazolo-[3,2-a] pyrimidine .The structures of the compounds obtained are set NMR, 13C, IR- spectroscopy.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer





